Skip to content

Research at St Andrews

Craving in opioid use disorder: from neurobiology to clinical practice

Research output: Contribution to journalReview article

Author(s)

Johan Kakko, Hannu Alho, Alexander Mario Baldacchino, Rocio Molina, Felice Alfonso Nava, Gabriel Shaya

School/Research organisations

Abstract

Opioid use disorder (OUD) is a major public health issue that has reached epidemic levels in some parts of the world. It is a chronic and complex neurobiological disease associated with frequent relapse to drug taking. Craving, defined as an overwhelmingly strong desire or need to use a drug, is a central component of OUD and other substance use disorders. In this review, we describe the neurobiological and neuroendocrine pathways that underpin craving in OUD and also focus on the importance of assessing and treating craving in clinical practice. Craving is strongly associated with patients returning to opioid misuse and is therefore an important treatment target to reduce the risk of relapse and improve patients’ quality of life. Opioid agonist therapies (OAT), such as buprenorphine and methadone, can significantly reduce craving and relapse risk, and it is essential that patients are treated optimally with these therapies. There is also evidence to support the benefits of non-pharmacological approaches, such as cognitive behavioral therapy and mindfulness-based interventions, as supplementary treatments to opioid agonist therapies. However, despite the positive impact of these treatments on craving, many OUD patients continue to suffer with negative affect and dysphoria. There is a clear need for further studies to progress our understanding of the neurobiological basis of craving and addiction and to identify novel therapeutic strategies as well as to optimize the use of existing treatments to improve outcomes for the growing numbers of patients affected by OUD.
Close

Details

Original languageEnglish
Article number592
Number of pages12
JournalFrontiers in Psychiatry
Volume10
DOIs
Publication statusPublished - 30 Aug 2019

    Research areas

  • Opiods, Craving, Addiction, Negative affect, Methadone, Buprenorphine

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Neurocognitive consequences of chronic cannabis use: a systematic review and meta-analysis

    Figureiredo, P., Tolomeo, S., Steele, D. & Baldacchino, A. M., 9 Nov 2019, In : Neuroscience and Biobehavioral Reviews. In press

    Research output: Contribution to journalArticle

  2. Effects of opioid dependence on visuospatial memory and its associations with depression and anxiety

    Tolomeo, S., Davey, F., Steele, J. D. & Baldacchino, A. M., 23 Oct 2019, In : Frontiers in Psychiatry. 10, p. 1-8 8 p., 743.

    Research output: Contribution to journalArticle

  3. Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders

    Liu, Y., van den Wildenberg, W. P. M., de Graaf, Y., Ames, S. L., Baldacchino, A., Bø, R., Cadaveira, F., Campanella, S., Christiansen, P., Claus, E. D., Colzato, L. S., Filbey, F. M., Foxe, J. J., Garavan, H., Hendershot, C. S., Hester, R., Jester, J. M., Karoly, H. C., Kräplin, A., Kreusch, F. & 35 others, Landrø, N. I., Littel, M., Steins-Löber, S., London, E. D., López-Caneda, E., Lubman, D. I., Luijten, M., Marczinski, C. A., Metrik, J., Montgomery, C., Papachristou, H., Park, S. M., Paz, A. L., Petit, G., Prisciandaro, J. J., Quednow, B. B., Ray, L. A., Roberts, C. A., Roberts, G. M. P., de Ruiter, M. B., Rupp, C. I., Steele, V. R., Sun, D., Takagi, M., Tapert, S. F., van Holst, R. J., Verdejo-Garcia, A., Vonmoos, M., Wojnar, M., Yao, Y., Yücel, M., Zack, M., Zucker, R. A., Huizenga, H. M. & Wiers, R. W., Oct 2019, In : Neuroscience and Biobehavioral Reviews. 105, p. 288-304

    Research output: Contribution to journalArticle

  4. Profiles of visuospatial memory dysfunction in opioid exposed and dependent populations

    Baldacchino, A., Tolomeo, S., Balfour, D. & Matthews, K., May 2019, In : Psychological Medicine. 49, 7, p. 1174-1184 27 p.

    Research output: Contribution to journalArticle

  5. Buprenorphine/naloxone and methadone opioid replacement therapy: a 2-year follow-up study and health economic analysis

    Kidd, B., Renwick, C., Parrott, S., Matthews, K. & Baldacchino, A. M., 3 Apr 2019, In : Journal of Addiction & Addictive Disorders. 6, 1, 9 p., 24.

    Research output: Contribution to journalArticle

Related by journal

  1. Effects of opioid dependence on visuospatial memory and its associations with depression and anxiety

    Tolomeo, S., Davey, F., Steele, J. D. & Baldacchino, A. M., 23 Oct 2019, In : Frontiers in Psychiatry. 10, p. 1-8 8 p., 743.

    Research output: Contribution to journalArticle

  2. Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation

    Young, A., Campbell, E. C., Lynch, S. J., Suckling, J. & Powis, S. J., 13 May 2011, In : Frontiers in Psychiatry. 2, 8 p., 27.

    Research output: Contribution to journalArticle

ID: 258519676

Top